Meerhoff T J, Paget W J, Aguilera J-F, van der Velden J
EISS Co-ordination Centre, Netherlands Institute for Health Services Research (NIVEL), Postbus 1568, 3500 BN Utrecht, The Netherlands.
Virus Res. 2004 Jul;103(1-2):31-3. doi: 10.1016/j.virusres.2004.02.009.
The European influenza surveillance scheme (EISS) is based on a surveillance model that combines clinical and virological data in the general population. Eighteen countries in Europe report weekly influenza activity to EISS (http://www.eiss.org). A questionnaire on the virological data collection was sent electronically to the EISS members. Questions on the specimen collection, representativity, laboratory diagnosis of influenza, reporting of variants, testing for other respiratory infections, serological testing, near-patient tests and preparedness for a pandemic were included. The results of the survey showed that for the typing of influenza, the methods polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA) and haemagglutination inhibition (HAI) methods are used most frequently. For the subtyping of influenza, HAI and PCR are used most often. An east-west divide was seen for the use of PCR in typing and subtyping (more PCR use in the west). Differences in the virological surveillance systems in Europe can make direct comparisons difficult because detection rates may differ by test. For the reporting of other respiratory infections besides influenza, many networks (68%) collect information on RSV. This is important because RSV causes similar clinical symptoms as influenza and can have a similar impact in terms of burden of disease. With the collection of RSV data, EISS is moving to a broader spectrum of viral respiratory diseases. The findings of this survey will be used to better harmonise laboratory methods in EISS in order to obtain more reliable and comparable information on influenza activity in Europe.
欧洲流感监测计划(EISS)基于一种将普通人群中的临床和病毒学数据相结合的监测模式。欧洲18个国家每周向EISS报告流感活动情况(http://www.eiss.org)。一份关于病毒学数据收集的调查问卷已通过电子邮件发送给EISS成员。问卷内容包括标本采集、代表性、流感的实验室诊断、变异株报告、其他呼吸道感染检测、血清学检测、即时检测以及大流行防范等问题。调查结果显示,在流感分型方面,聚合酶链反应(PCR)、酶联免疫吸附测定(ELISA)和血凝抑制(HAI)方法使用最为频繁。在流感亚型分型方面,HAI和PCR使用最为频繁。在PCR用于分型和亚型分型方面存在东西方差异(西方使用PCR的情况更多)。欧洲病毒学监测系统的差异可能导致难以进行直接比较,因为不同检测方法的检出率可能不同。对于除流感之外的其他呼吸道感染报告,许多网络(68%)收集呼吸道合胞病毒(RSV)的信息。这很重要,因为RSV会引发与流感相似的临床症状,并且在疾病负担方面可能产生类似影响。通过收集RSV数据,EISS正在转向更广泛的病毒性呼吸道疾病监测。本次调查结果将用于更好地统一EISS中的实验室方法,以便获取关于欧洲流感活动更可靠且可比的信息。